Trials / Completed
CompletedNCT00553293
Nordic Luveris Study
Recombinant LH Supplementation to Recombinant FSH During the Final Days of Controlled Ovarian Stimulation for IVF: a Multicentre, Prospective, Randomized, Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 526 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- Female
- Age
- 21 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | recombinant luteinizing hormone (Luveris) | 75 iu/day form cycle day 6 |
| DRUG | recombinant follicle stimulating hormone (Gonal-f) | rFSH 150 iu/day |
Timeline
- Start date
- 2003-08-01
- Completion
- 2004-11-01
- First posted
- 2007-11-05
- Last updated
- 2007-11-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00553293. Inclusion in this directory is not an endorsement.